Christine R Borge1, Anne Marit Mengshoel2, Ernst Omenaas3, Torbjørn Moum4, Inger Ekman5, Martha P Lein6, Ulrich Mack6, Astrid K Wahl2. 1. Department of Health Sciences, University of Oslo, Norway; Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway. Electronic address: c.r.borge@medisin.uio.no. 2. Department of Health Sciences, University of Oslo, Norway. 3. Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway. 4. Department of Behavioral Sciences in Medicine, University of Oslo, Norway. 5. Institute of Health and Care Sciences, the Sahlgrenska Academy, University of Gothenburg Sweden and Centre for Person-centered care, University of Gothenburg, Sweden. 6. Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway.
Abstract
OBJECTIVE: To investigate whether guided deep breathing using a device improves breathlessness, quality of life, and breathing pattern in moderate and severe stage of chronic obstructive pulmonary disease (COPD). METHODS: In total, 150 patients participated in a double-blind randomized controlled trial in a four-week intervention and a four-month follow-up. Participants were randomized into a guided deep breathing group (GDBG), music listening group (MLG), or sitting still group (SSG). The patients' symptom score using the St George's Respiratory Questionnaire (SGRQ), and a Global Rating Change scale (GRC) was applied to measure breathlessness as primary outcome. The activity score and impact score of SRGQ, and breathing pattern were secondary outcomes. RESULTS: Positive effects of the GDBG were detected in GRC scale in breathlessness at four weeks (p=0.03) with remaining effect compared to MLG (p=0.04), but not to SSG at four months follow-up. GDBG showed positive effect for respiratory rate (p<0.001) at four weeks follow-up. A positive significant change (p<0.05-0.01) was found in all groups of SGRQ symptom score. CONCLUSION:GDBG had a beneficial effect on respiratory pattern and breathlessness. MLG and SSG also yielded significant improvements. PRACTICE IMPLICATIONS: Guided deep breathing may be used as a self-management procedure.
RCT Entities:
OBJECTIVE: To investigate whether guided deep breathing using a device improves breathlessness, quality of life, and breathing pattern in moderate and severe stage of chronic obstructive pulmonary disease (COPD). METHODS: In total, 150 patients participated in a double-blind randomized controlled trial in a four-week intervention and a four-month follow-up. Participants were randomized into a guided deep breathing group (GDBG), music listening group (MLG), or sitting still group (SSG). The patients' symptom score using the St George's Respiratory Questionnaire (SGRQ), and a Global Rating Change scale (GRC) was applied to measure breathlessness as primary outcome. The activity score and impact score of SRGQ, and breathing pattern were secondary outcomes. RESULTS: Positive effects of the GDBG were detected in GRC scale in breathlessness at four weeks (p=0.03) with remaining effect compared to MLG (p=0.04), but not to SSG at four months follow-up. GDBG showed positive effect for respiratory rate (p<0.001) at four weeks follow-up. A positive significant change (p<0.05-0.01) was found in all groups of SGRQ symptom score. CONCLUSION:GDBG had a beneficial effect on respiratory pattern and breathlessness. MLG and SSG also yielded significant improvements. PRACTICE IMPLICATIONS: Guided deep breathing may be used as a self-management procedure.
Authors: David S Black; Chun Nok Lam; Nathalie T Nguyen; Ugonna Ihenacho; Jane C Figueiredo Journal: J Altern Complement Med Date: 2016-05-10 Impact factor: 2.579